Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALKS 2680
ALKS 2680
Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1
Clinical Trials Arena
Thu, 04/25/24 - 11:26 am
Alkermes
clinical trials
ALKS 2680
narcolepsy
Alkermes reports data from Phase Ib narcolepsy treatment trial
Clinical Trials Arena
Wed, 04/10/24 - 06:00 pm
Alkermes
clinical trials
narcolepsy
ALKS 2680
Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680
Drugs.com
Tue, 10/10/23 - 11:47 pm
Alkermes
ALKS 2680
narcolepsy